Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report

Giuseppina Novo, Egle Corrado, Cinzia Nugara, Cinzia Nugara, Giuseppe Coppola, Antonino Mignano, Giuseppina Novo, Antonino Saladino, Giusy Morgante, Giuseppina Novo, Antonino Saladino, Egle Corrado, Giuseppe Coppola

Research output: Contribution to journalArticlepeer-review

Abstract

Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling and arrhythmic reduction in a patient treated with sacubitril/valsartan.
Original languageEnglish
Pages (from-to)1349-1352
Number of pages4
JournalClinical Case Reports
Volume8
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report'. Together they form a unique fingerprint.

Cite this